Our Vision
The Obesity and Diabetes Research Institute will aim to improve the lives of those with obesity and diabetes through safe, effective and accessible treatment while researching new and more effective drugs and technologies for treatment.
The Problem of Obesity
Obesity and diabetes has reached epidemic proportions in the United States and many other parts of the world. It has created physical, psychological, social and economic drain on nations. Not surprisingly, it has become the focus of major initiatives from both Governments and the private sector. This epidemic has affected every state in the United States, with the greatest rise in incidence in those whose body mass index is over 40.
Obesity is complicated by metabolic diseases, the most important of which is type II diabetes mellitus. The rise in prevalence of type II diabetes has mirrored that of obesity. Both obesity and diabetes exact a toll on individuals, families and society as a whole and as such it is important to develop strategies that will have a far reaching impact on the prevalence of these diseases.
Current Research
One goal of our research is the advancement of clinical and basic science related to obesity and diabetes and with it the generation of intellectual property. Revenue is utilized for additional research and facilities funding so that the faculty can focus on the science rather than grant writing. Learn more about our current research.
Investor Relations
Our strategy will be to position ourselves, by leveraging our combined
clinical and research resources, to become a major research and
development pipeline which will be sought after by the pharmaceutical,
life sciences and medical devices industries.
Recepient: 2007 Innovator Award from Cleveland Clinic Innovations
Patent Attorney:
|
The Institute is the vision of Paul Thodiyil MD, who completed a fellowship in advanced laparoscopic and bariatic surgery at the Cleveland Clinic in 2005 and became a recipient of the "2007 Innovators Award" from Cleveland Clinic Innovations.
The Institute will
offer a range of clinical services, including weight loss surgery. The
research division will develop new treatments, generating and
commercializing new devices and licensable intellectual property. Integrated conference and hotel facilities will provide necessary resources to facilitate collaborative research, education and training. (read more)
Management is provided by a very educated and talented team that is supported by a Specialist Advisory Board. This consists of a panel of leading figures from the clinical and life sciences, management and information technology sectors who will provide high-level advice that will assist the Chairman and the Board of Directors in formulating policies to advance the strategic vision of the Institute.
|